José Luis Aguilar
Cayetano Heredia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by José Luis Aguilar.
Journal of Ethnopharmacology | 2002
José Luis Aguilar; Percy Rojas; Adolfo Marcelo; Alberto Plaza; Rudolf Bauer; Eveline Reininger; Christoph A. Klaas; Irmgard Merfort
We assessed in vivo the anti-inflammatory activity of two Cats claw bark extracts, by comparing a spray-dried hydroalcoholic extract against an aqueous freeze-dried extract, to determine which extract was more effective. We used the carrageenan-induced paw edema model in mice. In addition, to assess the molecular mechanism of action, we determined the inhibition of NF-kappa B through the Electrophoretic Mobility Shift Assay (EMSA) and the effects on cycloxygenase-1 and -2. Results showed that the anti-inflammatory activity was significantly higher using the hydroalcoholic compared with the aqueous extract (P<0.05). The extracts also showed little inhibitory activity on cyclooxygenase-1 and -2. It cannot be excluded that the slight inhibitory activity on DNA binding of NF-kappa B is due to cytotoxic effects.
Journal of Ethnopharmacology | 2010
Arturo Alejandro Dreifuss; Amanda Leite Bastos-Pereira; Thiago Vinicius Ávila; Bruna da Silva Soley; Armando J. Rivero; José Luis Aguilar; Alexandra Acco
AIM OF THE STUDY The present work intended to study the antitumoral and antioxidant effects of Uncaria tomentosa (UT) hydroalcoholic extract in the Walker-256 cancer model. METHODS AND MATERIALS Walker-256 cells were subcutaneously inoculated in the pelvic limb of male Wistar rats. Daily gavage with UT extract (10, 50 or 100 mg kg(-1), Groups UT) or saline solution (Control, Group C) was subsequently initiated, until 14 days afterwards. For some parameters, a group of healthy rats (Baseline, Group B) was added. At the end of treatment the following parameters were evaluated: (a) tumor volume and mass; (b) plasmatic concentration of urea, alanine aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyltransferase (GGT) and lactate dehydrogenase (LDH); (c) hepatic and tumoral activity of catalase (CAT) and superoxide dismutase (SOD), as well as the rate of lipid peroxidation (LPO) and gluthatione (GSH); and (d) hepatic glutathione-S-transferase (GST) activity. The reactivity of UT extract with the stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH) was assessed in parallel. RESULTS UT hydroalcoholic extract successfully reduced the tumor growth. In addition, treatment with UT reduced the activity of AST, which had been increased as a result of tumor inoculation, thus attempting to return it to normal levels. UT did not reverse the increase of LDH and GGT plasma levels, although all doses were remarkably effective in reducing urea plasma levels. An important in vitro free radical-scavenging activity was detected at various concentrations of UT extract (1-300 microg mL(-1)). Treatment also resulted in increased CAT activity in liver, while decreasing it in tumor tissue. SOD activity was reduced in liver as well as in tumor, compared to Group C. No statistical significance concerning ALT, GST, LPO or GSH were observed. CONCLUSIONS This data represent an in vivo demonstration of both antitumoral and antioxidant effects of UT hydroalcoholic extract. The antineoplastic activity may result, partially at least, from the ability of UT to regulate redox and metabolism homeostasis.
Transactions of The Royal Society of Tropical Medicine and Hygiene | 2003
Maria Cecilia Huaman; Yoshiya Sato; José Luis Aguilar; Angélica Terashima; Humberto Guerra; Eduardo Gotuzzo; Hiroji Kanbara
Routine microscopical examination of stool specimens for diagnosis of strongyloidiasis is insensitive and serological methods using Strongyloides stercoralis antigen are at present not available for field studies. We evaluated 2 techniques, enzyme-linked immunosorbent assay (ELISA) and gelatin particle indirect agglutination (GPIA), using an antigen obtained from the rodent parasite, S. venezuelensis. Fifty-four Peruvian patients with different clinical forms of strongyloidiasis were studied: 12 asymptomatic, 31 symptomatic, and 11 hyperinfection cases. Our results demonstrate that both ELISA and GPIA using S. venezuelensis antigen are useful for diagnosis of strongyloidiasis, with sensitivities of 74.1% and 98.2%, respectively and a specificity of 100% for both techniques. We found that GPIA is a highly sensitive test for patients with suspected chronic infection and/or hyperinfection. In the hyperinfection cases, significantly lower concentrations of specific immunoglobulin antibodies and eosinophils (P < 0.001) were found compared with the asymptomatic and symptomatic cases.
Revista Peruana de Medicina Experimental y Salud Pública | 2016
Willy Ceron; Iván Lozada-Requena; Kiomi Ventocilla; Sandra Jara; Milagros Pinto; Marco Cabello; José Luis Aguilar
In recent years, mesenchymal stem cells (MSC) have become very important due to their high plasticity and their ability to release paracrine factors able to interact with various cell types, tissues and organs. The use of MSC in regenerative medicine became of vital importance, since they do not express histocompatibility MHC molecules class II nor costimulant molecules, and low expression of MHC class I, will not be rejected by individuals of same species, they could be used in an autologous, and eventually, allogeneic manner. However, it is important to scientifically demonstrate many properties, including immunomodulatory ones. Having several sources of obtaining, it should be standardized the best one to ensure the purity and quality of these cells. Finally, it is important when working with these cells, that characteristics of cell culture, immunophenotyping and differentiation capacity are fully demonstrated. MSC have been applied in several clinical uses. Among them, their ability to improve, and even heal chronic ulcers, as diabetic, has attracted attention for its potential therapeutic impact.
Haemostasis 30(Suppl | 2000
Belsy Guerrero; M. Alves Pinto; Carlos Alberto Muller; S. A. Chermont; José Luis Aguilar; A. Gil; Cl Arocha Pinango
Revista Peruana de Medicina Experimental y Salud Pública | 2009
Iván Lozada-Requena; César Núñez; Yubell Álvarez; José Luis Aguilar
Archive | 1994
José Luis Aguilar; Guido Mazzotti; Luis Cuéllar; Pablo Campos; Eduardo Gotuzzo
Revista Peruana de Medicina Experimental y Salud Pública | 2016
Karen Paco; Luis Alberto Ponce-Soto; Marco Lopez-Ilasaca; José Luis Aguilar
Revista Peruana de Medicina Experimental y Salud Pública | 2015
Iván Lozada-Requena; César Núñez; José Luis Aguilar
Acta andin | 2000
Aida Moraima Tapia Huanambal; Carlos López; Adolfo Marcelo; José Luis Aguilar